Search

everythinglearnresearchcommunity

for

Search:↓

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Finasteride effectively blocks rat enzymes, but with varying methods and strength.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

Rivaroxaban and fondaparinux are effective for certain blood conditions, and hydroxyurea helps in sickle cell disease.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Oral baricitinib is effective and safe for treating alopecia areata.

Analog 23 is a promising compound for prostate cancer treatment.

A new treatment for hair loss shows promise with fewer side effects.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

The inhibitor affects androgen metabolism but not ovarian function.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

12-Methoxy carnosic acid from rosemary might be a good natural treatment for hair loss.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Gene differences may affect baldness treatment response in Korean men.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.